These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1036929)

  • 1. [The geriatric pharmacology of cefazolin, cefradin and sulfisomidine].
    Simon C; Malerczyk V; Tenschert B; Möhlenbeck F
    Arzneimittelforschung; 1976; 26(7):1377-82. PubMed ID: 1036929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin.
    Pabst J; Leopold G; Ungethüm W; Dingeldein E
    Arzneimittelforschung; 1979; 29(2a):437-43. PubMed ID: 582722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics and clinical experience with a new cephalosporin-derivative: cefazolin.
    Lode H; Gebert S; Hendrischk A
    Chemotherapy; 1975; 21(1):19-32. PubMed ID: 1097207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood levels and tissue concentrations of cefazedone in animals.
    Dingeldein E; Wahlig H
    Arzneimittelforschung; 1979; 29(2a):400-3. PubMed ID: 582715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.
    Philipson A; Stiernstedt G; Ehrnebo M
    Clin Pharmacokinet; 1987 Feb; 12(2):136-44. PubMed ID: 3829560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement.
    Cunha BA; Gossling HR; Pasternak HS; Nightingale CH; Quintiliani R
    J Bone Joint Surg Am; 1977 Oct; 59(7):856-9. PubMed ID: 908715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. I. Tolerance in comparison with cefazolin.
    Ungethüm W; Leopoid G
    Arzneimittelforschung; 1979; 29(2a):435-6. PubMed ID: 582721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of cephradine and cefazolin into ulcers of patients suffering from peripheral arterial circulatory insufficiency.
    Rylander M; Mannheimer C; Brorson JE
    Scand J Infect Dis; 1979; 11(4):281-6. PubMed ID: 531521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of intraperitoneal cefazolin in patients undergoing peritoneal dialysis.
    Kaye D; Wenger N; Agarwal B
    Antimicrob Agents Chemother; 1978 Sep; 14(3):318-21. PubMed ID: 708010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution and elimination of cefazolin in patients with normal renal function.
    Bergan T; Digranes A; Schreiner A
    Chemotherapy; 1978; 24(5):277-82. PubMed ID: 352636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.
    Smyth RD; Pfeffer M; Glick A; Van Harken DR; Hottendorf GH
    Antimicrob Agents Chemother; 1979 Nov; 16(5):615-21. PubMed ID: 526003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid.
    Walstad RA; Hellum KB; Blika S; Dale LG; Fredriksen T; Myhre KI; Spencer GR
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():275-82. PubMed ID: 6352632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentration of cefamandole in human renal parenchyma (author's transl)].
    Kroening U; Brückner O; Nagel R
    Arzneimittelforschung; 1981; 31(11):1976-9. PubMed ID: 7198478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The concentrations of cephalosporins in tissue fluid of rats with localized infection.
    Polacek I
    Biopharm Drug Dispos; 1981; 2(1):69-77. PubMed ID: 7016213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological study of cefazolin during intermittent and continuous infusion: a crossover investigation in humans.
    Thys JP; Vanderkelen B; Klastersky J
    Antimicrob Agents Chemother; 1976 Sep; 10(3):395-8. PubMed ID: 984782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits.
    Carbon C; Contrepois A; Brion N; Lamotte-Barrillon S
    Antimicrob Agents Chemother; 1977 Apr; 11(4):594-8. PubMed ID: 856011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biliary excretion of cefazolin.
    Brogard JM; Dorner M; Pinget M; Adloff M; Lavillaureix J
    J Infect Dis; 1975 Jun; 131(6):625-33. PubMed ID: 805810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.
    Vree TB; Hekster YA; Tijhuis MW; Baakman M; Oosterbaan MJ; Termond EF
    Pharm Weekbl Sci; 1984 Aug; 6(4):150-6. PubMed ID: 6483571
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.